Evidence map›Paper›PMID 40303221›Full record

ArticleKidney international reports2025

Erratum to "Anticoagulation for the Prevention of Thrombotic Events in Nephrotic Syndrome" [

David Massicotte-Azarniouch, Daniel J Crona, Priscilla Karnabi, Bhadran Bose, Patrick H Nachman, Marc Carrier, Mark Canney, David W Johnson, Taewoo Lee, Raja Ramachandran and 3 more

Abstract readPublished Erratum
In one paragraph

Article in Kidney international reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

David Massicotte-AzarniouchDivision of Nephrology, Department of Medicine, University of Ottawa and the Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
Daniel J CronaDivision of Pharmacotherapy and Experimental Therapeutics, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, North Carolina, USA.
Priscilla KarnabiClinical Epidemiology Program, the Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
Bhadran BoseDepartment of Nephrology, Nepean Hospital, Kingswood, New South Wales, Australia.
Patrick H NachmanDivision of Nephrology and Hypertension, Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA.
Marc CarrierDepartment of Medicine, University of Ottawa at The Ottawa Hospital, Ottawa, Ontario, Canada.
Mark CanneyDivision of Nephrology, Department of Medicine, University of Ottawa and the Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
David W JohnsonDepartment of Kidney and Transplant Services, University of Queensland at Princess Alexandra Hospital, Brisbane, Queensland, Australia.
Taewoo LeeDivision of Nephrology, Department of Internal Medicine, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA.
Raja RamachandranDepartment of Nephrology, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
Vivekanand JhaGeorge Institute for Global Health, University of New South Wales, New Delhi, India.
Nigel S KeyDivision of Hematology, Department of Medicine, UNC Blood Research Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Vimal K DerebailDivision of Nephrology and Hypertension, Department of Medicine, UNC Kidney Center, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[This corrects the article DOI: 10.1016/j.ekir.2024.07.013.].

Identifiers

PMID40303221
PMCPMC12034856

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.